The effect of CoQ10 supplementation on neuropathic symptoms, blood glucose and some inflammatory and antioxidant parameters in patients with type 2 diabetes

Shahid Sadoughi University of Medical Sciences and Health Services0 个研究点目标入组 70 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•1.The agreement of the patients to contribute in the trial; 2. patients that have type two diabetes for at least 5 years; 3.The patients should have neuropathy symptoms that have been recognized by a physician (The patients’ score on the Michigan score should be at least 8 and their nerve reflexes should be weak); 4.The patients should not have any other neurologic, kidney or hepatic diseases; 5.If the patients take medicine for neuropathy, the dosage of their medicine should not change during the trial; 6.If the patients have not taken a medicine at the beginning of the trial, they should not start taking it during the trial; 7.The patients should not have taken antioxidant supplements from the past 3 months. Exclusion criteria 1.If a dosage of a patient's medicine changes that patient will be excluded from the trial; 2.If a patient who has not taken any medicine for his neuropathy starts to take a medicine during the trial that patient will be excluded from the trial; 3.Pregnancy and lactation.

发起方